MONDAY, Jan. 31, 2022 (HealthDay News) — Yet another study is chipping away at the idea that colon and rectal cancers are diseases of older age: In the past couple decades, Americans younger than 40 have shown the steepest rise in advanced cases of these cancers. The research adds toContinue Reading
MONDAY, Jan. 31, 2022 (HealthDay News) — Most American adults don’t know that alcohol boosts cancer risk, but a majority support steps to increase awareness of the link, a new nationwide survey shows. “”It is important that people are made fully aware of the potential harms of alcohol so thatContinue Reading
FRIDAY, Jan. 28, 2022 (HealthDay News) — When delivering a liver cancer diagnosis, Dr. Thomas Marron pulls no punches: “Liver cancer is one of the deadliest cancers,” he tells patients. Jeffrey Foster heard a similar message loud and clear when he was first diagnosed by another doctor with hepatocellular carcinomaContinue Reading
THURSDAY, Jan. 27, 2022 (HealthDay News) — Finding the right medication for rheumatoid arthritis isn’t easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms. The study was mandated by the U.S. Food andContinue Reading
TUESDAY, Jan. 25, 2022 (HealthDay News) — Americans, get up out of that chair and get moving. If everyone between 40 and 85 years of age were active just 10 minutes more a day, it could save more than 110,000 U.S. lives a year, a large study reports. “Our projectionsContinue Reading
SATURDAY, Jan. 22, 2022 (HealthDay News) — Tobacco use is far and away the leading cause of lung cancer, but non-smokers are also at risk, experts say. People who smoke have the highest risk, and smokeless tobacco is also a threat. About 90% of lung cancer cases could be preventedContinue Reading
THURSDAY, Jan. 20, 2022 (HealthDay News) — Skin side effects caused by cancer drugs called immune checkpoint inhibitors may be a telltale sign that the drugs are working, according to a new study. Immune checkpoint inhibitors, a type of immunotherapy, boost the body’s immune response against tumor cells and haveContinue Reading
WEDNESDAY, Jan. 19, 2022 (HealthDay News) — Even in a setting where white and Black people have equal access to medical care, Black Americans fare worse than whites in terms of prostate cancer, new research shows. A review of nearly 8 million men seen at America’s Veterans Affairs (VA) hospitalsContinue Reading
WEDNESDAY, Jan. 19, 2022 (HealthDay News) — Big surprise bills for any colonoscopy done after a positive result from a stool-based screening test will be prevented under new federal rules, a group of U.S. medical organizations say. On Jan. 10, the Biden administration issued guidance requiring private insurers to coverContinue Reading
TUESDAY, Jan. 18, 2022 (HealthDay Now) — Advanced forms of hormone therapy are very effective at keeping prostate cancer in check, but they also can double a man’s risk of falling into depression, researchers have found. Prostate cancer patients treated with the latest forms of hormone blockers were twice asContinue Reading